Loading page…

Report overview

The report describes a strong 2021 for the Evotec Group, with Group revenues rising 23% to € 618.0 m and the company expanding its biologics manufacturing footprint through the opening of J.POD Redmond. It reports 4,198 employees at year-end and highlights continued investment in R&D, sites and partnerships. The report directs readers to a separate Sustainability Report 2021 for detailed ESG performance, covering global health, people and DEI, the planet and compliance.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Publication date: 26 April 2022
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

No standards or assurance data is available for this report.

ESG & Materiality

ESG data

Indicators available in this report:

Employees
Women on the board
Women in management

No materiality data is available for this report.

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown for your project.

Explore our services